Anneke Van Der Walt

Projects

Projects per year 2015 2018 2019 2021 2027

• 15 Finished
• 17 Active

Projects per year

Search results

• Active

  MSBase Fellowship Award

  Sajedi, S. A., Van Der Walt, A. & Zhu, C.

  3/03/23 → 3/03/24

  Project: Research

• A Phase III randomised, placebo-controlled, double-blind, multi-centre, clinical trial to determine the efficacy and safety of Presendin in idiopathic intracranial hypertension

  Van Der Walt, A.

  17/02/23 → 17/02/25

  Project: Research

• VALUE-Ig : eVidence synthesis to inform the optimAL UsE of Immunoglobulin

  Petrie, D., McQuilten, Z., Harris, A., Wood, E., Irving, A., Van Der Walt, A., Reddel, S. W., Fanning, L., Spencer, A., Hawkes, E. & Crispin, P.

  1/04/22 → 31/03/25

  Project: Research

• Determining the risk of cervical precancer and cancer in women with multiple sclerosis: a national data linkage study.

  Van Der Walt, A., Jokubaitis, V., Butzkueven, H., Taylor, B. V. M., Lechner-Scott, J. & Brotherton, J. M. L.

  Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited)

  1/01/22 → 31/12/24

  Project: Research

• Active monitoring of cognitive function to detect preclinical changes and define longitudinal cognitive trajectories in people with multiple sclerosis

  Merlo, D. & Van Der Walt, A.

  Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited)

  1/01/22 → 31/12/24

  Project: Research

• VISIONARY-MS LTE: A Multi-Centre, Open-Label Long-Term Extension Study Assessing the Safety, Efficacy, Tolerability, and Pharmacokinetics of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis (RMS) under Protocol number CNMAu8.201LTE

  Van Der Walt, A.

  29/07/21 → 31/12/26

  Project: Research

• A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.

  Van Der Walt, A. & Macdonnell, R.

  16/03/21 → 31/12/26

  Project: Research

• Multi-dimensional monitoring of cognition and cerebellar function to prospectively define disease progression in multiple sclerosis

  Van Der Walt, A.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/21 → 31/12/25

  Project: Research

• Active self-monitoring to prospectively detect treatment failure and define subclinical progression trajectories in multiple sclerosis: The ACTIVE-MS Program.

  Van Der Walt, A., Butzkueven, H., Jokubaitis, V., Kolbe, S., Vogel, A. P., Stankovich, J., Butler, E., Macdonell, R. A. L. & Darby, D.

  Trish Multiple Sclerosis Research Foundation

  1/01/20 → 31/12/23

  Project: Research

• Monash-Roche Meaningful Data at Scale Collaboration for MS

  Van Der Walt, A. & Butzkueven, H.

  Hoffmann-La Roche (Switzerland)

  6/12/19 → 31/12/27

  Project: Research

• Collaboration on Roche Managed Primary Data Collection NIS and RWD Analytics Activities

  Butzkueven, H. & Van Der Walt, A.

  Hoffmann-La Roche (Switzerland)

  6/12/19 → 1/12/26

  Project: Research

• A prospective, multicenter, observational, post-authorization safety study to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (Post Authorization Safety Study (PASS) Protocol).

  Van Der Walt, A.

  31/07/19 → 31/12/24

  Project: Research

• Active Participatory Health Monitoring in people with Multiple Sclerosis to improve treatment outcomes (Active-MS)

  Butzkueven, H., Van Der Walt, A., Darby, D., Stankovich, J., Jokubaitis, V., Skibina, O., Marriott, M., Butler, E. & Gresle, M.

  Department of Health and Aged Care (Australia)

  1/07/19 → 30/06/24

  Project: Research

• A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching from Treatment with 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment Followed by an Open-Label Crossover Extension Study Comprising Subcutaneous and Intravenous Natalizumab Administration

  Van Der Walt, A.

  16/04/19 → 31/12/24

  Project: Research

• Next generation biomarkers for multiple sclerosis

  Van Der Walt, A., Kolbe, S., Butzkueven, H., Kalincik, T. & Kilpatrick, T. J.

  Biogen Australia Pty Ltd

  1/01/19 → 15/12/23

  Project: Research

• Long-term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another disease-modifying therapy.

  Van Der Walt, A. & Germaine, J.

  30/11/18 → 31/01/24

  Project: Research

• VISIONARY-MS: A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study for the Treatment of Visual Pathway Deficits in Chronic Optic Neuropathy to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of CNM-Au8 For Remyelination In Stable Relapsing-Remitting Multiple Sclerosis (RRMS).

  Van Der Walt, A.

  19/10/18 → 31/12/25

  Project: Research

• Finished

  Immune phenotyping and Disease modifying treatments in MS – implications for treatment response and infection.

  Van Der Walt, A., Monif, M. & Butzkueven, H.

  1/01/21 → 31/12/21

  Project: Research

• SARS-CoV2 antibody-seroprevalence in patients with MS.

  Van Der Walt, A., Brilot-Turville, F. & Broadley, S. A.

  1/01/21 → 31/12/21

  Project: Research

• The Australian and New Zealand Multiple Sclerosis and Neuroimmunology COVID-19 virus data registry

  Van Der Walt, A., Broadley, S. & Mason, D.

  Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited)

  18/05/20 → 21/05/21

  Project: Research

• Pharmacogenomic prediction of treatment response in multiple sclerosis

  Van Der Walt, A., Jokubaitis, V. & Butzkueven, H.

  21/10/19 → 20/04/20

  Project: Research

• NHMRC Equipment Grant - Quanterix SIMOA HD-1 Analyser

  Shultz, S., Kwan, P., Medcalf, R., O'Brien, T., Mitra, B., Coughlan, M., Jones, N., Van Der Walt, A., Butzkueven, H., Semple, B. & Hutton, E.

  Monash University – Internal Faculty Contribution, Monash University – Internal Department Contribution

  1/01/19 → 31/12/19

  Project: Research

• MSPP: Multiple Sclerosis: Pregnancy and Prognosis

  Jokubaitis, V., Van Der Walt, A., Hellwig, K., McCombe, P. & Stankovich, J.

  1/01/19 → 31/12/22

  Project: Research

• MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.

  Van Der Walt, A.

  17/12/18 → 30/11/22

  Project: Research

• PhD Project: Altered Vitamin D responsiveness in Multiple Sclerosis Immune Cells.

  Butzkueven, H., Van Der Walt, A., Stankovich, J., Jokubaitis, V. & Monif, M.

  Roche Australia

  16/10/18 → 1/01/20

  Project: Research

• MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.

  Van Der Walt, A. & Lechner-Scott, J.

  5/10/18 → 30/11/22

  Project: Research

• MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.

  Van Der Walt, A.

  4/10/18 → 30/11/22

  Project: Research

• TOP: TYSABRI Observational Program

  Van Der Walt, A.

  4/10/18 → 4/10/23

  Project: Research

• Prospective clinic and home-based serial monitoring of cognition in relapsing-remitting multiple sclerosis.

  Van Der Walt, A. & Butzkueven, H.

  13/09/18 → 13/11/22

  Project: Research

• Early diagnosis, pathophysiology and treatment of subclinical cognitive decline in multiple sclerosis

  Merlo, D. & Van Der Walt, A.

  20/03/18 → 19/03/21

  Project: Research

• Tremor and cognition in Multiple Sclerosis: implementing novel treatments and computerized monitoring strategies.

  Van Der Walt, A.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/18 → 31/12/20

  Project: Research

• Predicting treatment response to onabotulinumtoxin-a in MS-related tremor: a combined clinical, electrophysiological and neuroimaging approach.

  Van Der Walt, A. & Evans, A. H.

  1/01/15 → 30/06/20

  Project: Research